School of Medicine
Showing 151-160 of 244 Results
-
Jennifer Pien MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioJennifer H. Pien is a Clinical Associate Professor and Stanford Medical Humanities & Arts faculty through the Department of Psychiatry at Stanford University. She is the Director of The Pegasus Physician Writers, Founder of The Pegasus Review, and is on the faculty editorial team for the Oxford Review of Books x Stanford collaboration. She also serves on the Advisory Board for The Bellevue Literary Press and the Stanford School of Medicine Medical Humanities Fellowship. In addition to her work in Medical Humanities, her interests include advocacy for adults with developmental disabilities where she cofounded Puente Clinic through the San Mateo County Medical System, an innovative dev. disabilities subspecialty clinic. She serves on the Regional Advisory Committee to the California State Council on Developmental Disabilities. Currently, her clinical focus is on physician well-being through the WellConnect team.
-
Benjamin Pinsky
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
-
Harlan Pinto
Associate Professor of Medicine (Oncology) and of Otolaryngology - Head & Neck Surgery
Current Research and Scholarly InterestsClinical Interests: general oncology, head and neck cancer Research Interests: chemoprevention trials and combined modality approaches to head and neck cancer
-
Sharon Pitteri
Associate Professor (Research) of Radiology (Cancer Early Detection-Canary Center)
Current Research and Scholarly InterestsThe Pitteri laboratory is focused on the discovery and validation of proteins that can be used as molecular indicators of risk, diagnosis, progression, and recurrence of cancer. Proteomic technologies, predominantly mass spectrometry, are used to identify proteins in the blood that are differentially regulated and/or post-translationally modified with disease state. Using human plasma samples, tumor tissue, cancer cell lines, and genetically engineered mouse models, the origins of these proteins are being investigated. A major goal of this research is to define novel molecular signatures for breast and ovarian cancers, including particular sub-types of these diseases. This laboratory is also focused on the identification of proteins with expression restricted to the surface of cancer cells which can be used as novel targets for molecular imaging technologies.
